<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05798416</url>
  </required_header>
  <id_info>
    <org_study_id>2020 No.37</org_study_id>
    <nct_id>NCT05798416</nct_id>
  </id_info>
  <brief_title>Effect of Inhalation of Low Dose CO2 on Exercise Performance at High Altitude</brief_title>
  <official_title>Effect of Supplement of CO2 Using Novel Portable Device on Exercise Performance at High Altitude</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>State Key Laboratory of Respiratory Disease</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>State Key Laboratory of Respiratory Disease</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      High altitude (&gt;2400 m) is associated with decreased atmosphere pressure leading to hypoxia&#xD;
      which in turn impairs exercise capacity and causes acute mountain sickness (AMS). It is noted&#xD;
      that adding CO2 might be beneficial to improve hypoxia and exercise performance at high&#xD;
      altitude. However, no device is currently available that can supply a constant low dose of&#xD;
      CO2 during free movement at high altitude. We have recently invented a portable device which&#xD;
      is small and light enough for supplement of low dose CO2 during field exercise at high&#xD;
      altitude.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objective: To determine whether the supplement of low-dose CO2 by the novel device could&#xD;
      improve exercise performance at high altitude.&#xD;
&#xD;
      Methods: The lowlanders (&lt;500m) who have no history of travelling to high altitude (&gt;1000m) a&#xD;
      year before the study will be recruited. And the subjects who are high-altitude residents and&#xD;
      have not left high altitude over the last twelve months will also be recruited for the study.&#xD;
      Subjects will be randomly and blindly given either CO2 mixed with air or air alone during&#xD;
      endurance shuttle walking test (ESWT). Blood gases will be measured before and after&#xD;
      inhalation of CO2. ESWT time, ventilation per minute (VE), blood oxygen saturation (SPO2),&#xD;
      and end-tidal CO2 concentration (ETCO2) will be measured during exercise and will be compared&#xD;
      during inhalation of CO2 and during inhalation of ambient air.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">February 15, 2023</start_date>
  <completion_date type="Anticipated">April 29, 2023</completion_date>
  <primary_completion_date type="Actual">April 15, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of the distance in walking test</measure>
    <time_frame>48 hours</time_frame>
    <description>Changes in walking distance under inhalation of CO2 and ambient air</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>High Altitude</condition>
  <condition>Inhalation; Gas</condition>
  <condition>Acute Mountain Sickness</condition>
  <arm_group>
    <arm_group_label>Exercise under inhalation of CO2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects will perform shuttle walk test under inhalation of low concentration of CO2 supplied by a novel device at high altitude.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Exercise under inhalation of ambient air</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Subjects will perform shuttle walk test under inhalation of ambient air at high altitude.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Exercise under inhalation CO2</intervention_name>
    <description>Participants perform shuttle walk test at high altitude while using the novel portable device for inhalation of CO2</description>
    <arm_group_label>Exercise under inhalation of CO2</arm_group_label>
    <other_name>inhalation of low dose CO2</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Exercise under inhalation ambient air</intervention_name>
    <description>Participants perform shuttle walk test at high altitude while inhaling ambient air</description>
    <arm_group_label>Exercise under inhalation of ambient air</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Healthy lowlanders (&lt;500m) who have no history to travel to high altitude (&gt;1000m) a&#xD;
             year before the study.&#xD;
&#xD;
          2. Healthy high altitude (4500m) residents who have not left the inhabited area over the&#xD;
             last twelve months before the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        1. Subjects with cardiovascular diseases, respiratory diseases and neuromuscular diseases&#xD;
        which could affect exercise.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yuanming Luo, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Affiliated Hospital og Guangzhou Medical University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Guangzhou Medical University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2023</verification_date>
  <study_first_submitted>March 10, 2023</study_first_submitted>
  <study_first_submitted_qc>March 23, 2023</study_first_submitted_qc>
  <study_first_posted type="Actual">April 4, 2023</study_first_posted>
  <last_update_submitted>May 5, 2023</last_update_submitted>
  <last_update_submitted_qc>May 5, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">May 8, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>State Key Laboratory of Respiratory Disease</investigator_affiliation>
    <investigator_full_name>Yuan-Ming Luo</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>High altitude</keyword>
  <keyword>Exercise performance</keyword>
  <keyword>CO2 inhalation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Aspiration</mesh_term>
    <mesh_term>Altitude Sickness</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>The data will be shared after the paper of this study publishing.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_time_frame>The data will be shared after the paper of this study publishing.</ipd_time_frame>
    <ipd_access_criteria>After the paper of this study publishing</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

